IOnctura CEO On Pipeline Strategy And Funding Goals
Executive Summary
IOnctura’s CEO Catherine Pickering outlines the company’s business model and its approach to cancer R&D targeting the tumor microenvironment.
iOnctura SA's CEO Catherine Pickering talks to Scrip about the company’s founding, technology and checkpoint inhibitor combination strategy. Pickering also discusses IOnctura’s financing goals for 2018.